CLOs on the Move

Spyce Food Co.

www.spyce.com

 
We`re creating an original restaurant concept featuring a never before seen robotic kitchen. In collaboration with Chef Daniel Boulud, we`re excited to introduce you to Spyce.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Giorgio Foods, Inc.

Giorgio Foods, Inc. is one of the leading companies in the Manufacturing sector.

Edible Brands

Making the world a whole lot sweeter.

USEFULL

USEFULL is a tech-enabled circular economy solution designed to eliminate single-use food/beverage products. USEFULL empowers and enables corporate organizations, colleges, campuses, and communities to meet their zero waste goals.

Blue Marble

A family business with core values of work hard, play hard. We are proud to offer Ultra-Premium Co-Packing, Private Label, and Canning Services. Explore our award-winning line of Ultra-Premium beverages and join us in keeping the blue marble blue.

Neptune Technologies and Bioressources

Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.